Sonay İncesoy Özdemir

ORCID: 0000-0003-2863-901X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Vascular Malformations and Hemangiomas
  • Peptidase Inhibition and Analysis
  • Occupational and environmental lung diseases
  • Congenital Diaphragmatic Hernia Studies
  • Bone Tumor Diagnosis and Treatments
  • COVID-19 and healthcare impacts
  • Cancer Diagnosis and Treatment
  • Cancer Research and Treatments
  • Acute Lymphoblastic Leukemia research
  • Cardiac tumors and thrombi
  • Cancer Immunotherapy and Biomarkers
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Hepatitis Viruses Studies and Epidemiology
  • Genetic and Kidney Cyst Diseases
  • Vascular Tumors and Angiosarcomas
  • Vaccine Coverage and Hesitancy
  • Adolescent and Pediatric Healthcare
  • Renal and related cancers
  • Medical Imaging and Pathology Studies
  • Testicular diseases and treatments
  • Neurofibromatosis and Schwannoma Cases

Ankara University
2003-2025

Ankara Yıldırım Beyazıt University
2015-2022

Memorial Ankara Hospital
2021-2022

City Hospital
2021-2022

Ankara Onkoloji Eğitim ve Araştırma Hastanesi
2011-2022

Ankara Mevki Asker Hastanesi
2021

Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi
2019

Ministry of Health
2017

Pediatric Oncology Group
2017

Konya Eğitim ve Araştırma Hastanesi
2015

Objective: The role of cord milking as an alternative to delayed clamping is area that requires more research. Purpose this clinical trial was investigate the impact umbilical on absolute neutrophil counts (ANCs) and neutropenia frequency preterm infants.Methods: Fifty-eight pregnant women were randomly assigned one control groups. A total 54 infants (gestational age ≤32 weeks) enrolled into study. cords 25 clamped immediately after birth, in 29 infants, performed first.Results: ANCs...

10.3109/14767058.2015.1012067 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2015-03-03

Although hemangioendothelioma (HHE) is a commonly encountered hepatic tumor during infancy, HHE-related hypothyroidism rare. We present patient who developed the neonatal period and showed marked improvement in by regression of HHE. A 28-day-old boy with TSH level 77 mIU/mL on screening diagnosed as congenital was started L-thyroxine (L-T4) (11 μg/kg/day) therapy 21(th) day life. On physical examination, liver palpable 5 cm below right costal margin, thyroid gland nonpalpable. Thyroid...

10.4274/jcrpe.v2i3.126 article EN cc-by-nc-nd Journal of Clinical Research in Pediatric Endocrinology 2010-09-15

Background: Long-term survivors of Hodgkin lymphoma (HL) are at risk developing a range late effects, with second malignant neoplasm and cardiovascular diseases being the leading causes death in these patients. The present study aims to evaluate side effects children HL. Materials Methods: Out 53 HL patients, we assessed long-term childhood (HLSs; n = 50) diagnosed between 1998 2019. Patient data related chronic health conditions, sociodemographic characteristics were compared their siblings...

10.4103/ijc.ijc_912_20 article EN Indian Journal of Cancer 2024-01-09

e22002 Background: Pain is one of the most important problems that affects more than half cancer patients at any stage disease and disrupts quality life patients. The aim should be to relieve pain as soon possible prevent its recurrence. In this study, we aimed evaluate clinical characteristics our who were followed up with a diagnosis in clinic whose management was planned multidisciplinary manner department Algology. where study conducted reference center middle income developing country....

10.1200/jco.2024.42.16_suppl.e22002 article EN Journal of Clinical Oncology 2024-06-01

In our study, we aimed to share the clinical experiences of center regarding osteosarcoma cases, most common primary malignant bone tumor in children and adolescents. With approval from Clinical Research Ethics Committee center, data 59 pediatric patients who were followed up with diagnosis between 2007 2021 evaluated retrospectively. The mean time onset symptoms was 3 months. Although not statistically significant, a diagnostic delay months or less had higher rate recurrence mortality....

10.5152/turkarchpediatr.2024.24043 article EN cc-by-nc Turkish Archives of Pediatrics 2024-09-02

The aim of the present study was to evaluate efficiency and side effects mifamurtide in childhood osteosarcoma (OS). In total, 477 doses 2 mg/m intravenous (IV) mifamurtide, along with paracetamol as a premedication, were given 15 patients primary nonmetastatic OS after complete surgical resection 3 progressive OS. most common encountered chills fever (17/18). These reactions observed 4 during administration each dose, single patient last administration, remaining 12 first or initial...

10.1097/mph.0000000000001236 article EN Journal of Pediatric Hematology/Oncology 2018-06-10

In this study, clinical characteristics, treatment modalities and outcome of patients diagnosed with bladder/prostate rhabdomyosarcoma (BP RMS) were evaluated retrospectively. Files 8 children BP RMS treated between 2004-2014 reviewed for outcome. Seven males one female 2004-2014. Median age was 33.5 months (range, 2 to 176 months). At presentation the main symptoms hematuria in 5 patients, constipation, oliguria prolonged jaundice 1 patient each. All non-metastatic only had an embryonal...

10.24953/turkjped.2016.03.004 article EN cc-by The Turkish Journal of Pediatrics 2016-06-25

Non-Hodgkin lymphoma (NHL) includes pathologies of different clinical courses, treatments, outcomes. Our study aims to investigate the late effects NHL survivors (NHLS).Among 59 cases, 50 completed their treatment between 2003 and 2019. Out patients, cumulative survival rates event-free after 10 years since diagnosis were 82.9% ±5.2% 84.1% ±5.2%, respectively. In addition, we compared data related chronic health psychosocial conditions with siblings (n = 61).The age gender ratios similar in...

10.4103/jcrt.jcrt_80_21 article EN Journal of Cancer Research and Therapeutics 2022-01-01

Germ cell tumor (GCT) is a rare malignancy accounting for 2-3% of all pediatric tumors. The overall survival rate children and adolescents with GCT more than 80% after adopting combined therapy. aim this study to review clinical presentation, management, outcome in single-center series extracranial GCT. Clinical characteristics, pathologic presentations, outcomes 101 GCT, treated at our hospital from 1988 2011, were analyzed. Sixty-two patients female 39 them male. Fifty-eight (57%) had...

10.24953/turkjped.2017.04.007 article EN The Turkish Journal of Pediatrics 2017-08-25

Ewing`s sarcoma (ES) is the second most common childhood primary malignant tumor of bone. The popular locations ES are long bones and pelvis. involvement mandible very rare in childhood. In last 10 years, we met with three cases our department. Initially patients had symptoms similar to periodontal inflammation. might be considered inflammation its initial stages, what frequently leads delayed treatment. Although this has an aggressive clinical behavior rapid growth, early diagnosis can...

10.24953/turkjped.2017.06.015 article EN The Turkish Journal of Pediatrics 2017-12-25

Aim: The main purpose of this study is to determine the current status long-term follow-up (LTFU) for childhood cancer survivors and challenges LTFU pediatric at oncology institutions in Turkey. Material methods: A questionnaire was e-mailed directors 33 centers (POCs) registered Turkish Pediatric Oncology Group (TPOG). Of these active TPOG institutions, 21 participated returned their completed questionnaires. Results: Only 1 participating had a separate clinic. remaining provided care...

10.3906/sag-1911-193 article EN TURKISH JOURNAL OF MEDICAL SCIENCES 2020-07-06

Primary immune deficiencies are a group of heterogenous genetic disorders characterized by frequent infections, autoimmunity and malignancy. In this study, we aimed to evaluate clinical characteristics, outcomes children with malignancy developed on background primary immunodeficiency compare survival rates patients between malignant lymphoma without from tertiary oncology center in developing country. A total 23 were evaluated retrospectively. 26 malignancies (first or second) determined....

10.1080/08880018.2022.2045408 article EN Pediatric Hematology and Oncology 2022-03-12

An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.

10.1017/s0317167100017030 article EN Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2005-02-01

Bevacizumab is a monoclonal human antibody that effective in the treatment of cancers both adults and children due to inhibition vascular endothelial growth factor. Throbotic microangiopathy (TMA) well-known complication bevacizumab. Herein, we report case desmoplastic small round cell tumor 17-year-old male presenting with TMA after bevacizumab treatment. Eculizumab was administered as second line agent for thrombotic partial remission achieved. With this would like emphasize renal effects...

10.1016/j.phoj.2022.08.006 article EN cc-by-nc-nd Pediatric Hematology Oncology Journal 2022-09-03
Coming Soon ...